Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?
Author(s): Rajalakshmi Santhanakrishnan Added: 3 years ago
Heart failure (HF) is a major health problem and about 6 million adults are affected in the US alone, at a cost of approximately $20 billion per year.1 Despite the availability of new treatment strategies, the incidence, number of hospitalizations and mortality associated with HF remains a big health burden.1 In addition to increasing age, the factors that contribute to poor prognosis for people… View more

Heart Failure
Job title: Head of the EP Lab and Professor
Personal History Prof Marek Jastrzębski is a heart rhythm specialist, professor and head of the EP Laboratory at Jagiellonian University in Kraków, Poland. He was the first electrophysiologist in Poland.1, 4 In his spare time, Prof Jastrzębski enjoys classic photography, snowboarding and beekeeping.1 Academic History In 1995, Prof Jastrzębski graduated from Jagiellonian University… View more
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions. What late-breaking trials should we look out for? Which results are likely to impact your practice? What are the considerations and challenges? Trials covered in detail include: 37s:… View more

Standards & Guidelines

Heart Failure
Jeffrey W Moses
Research Area(s) / Expertise: Job title: Director of Interventional Cardiovascular Therapeutics
Dr Moses currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. Dr. Moses is an Associate Director of the Transcatheter Cardiovascular Therapeutics (TCT) conference, the world’s largest interventional cardiology conference. He serves on… View more
ESC 23: LIBerate-HeFH Study
Author(s): Frederick Raal Added: 7 months ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104). The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in… View more

Heterogeneous Populations

Prevention & Chronic Conditions
Author(s): Srinivas Murali Added: 3 years ago
Pulmonary arterial hypertension (PAH) is a disease affecting the pulmonary vascular endothelium of the small pulmonary vessels that causes progressive elevations in pulmonary vascular resistance, leading to right ventricular failure and death. PAH can result from a number of causes or associated risk factors. A clinical classification (Evian classification) was developed in 1993 and subsequently… View more

Prevention & Chronic Conditions
Bernard J Gersh
Research Area(s) / Expertise: Job title: Professor of Medicine
Professor of Medicine at Mayo Clinic College of Medicine, Consultant in Cardiovascular Diseases and Internal Medicine. His past positions include The W. Proctor Harvey Teaching Professor of Cardiology and Chief of the Division of Cardiology at Georgetown University Medical Center. Dr. Gersh received his MB, ChB, from the University of Cape Town in South Africa. He received his Doctor of… View more
Job title: Cardiac Electrophysiologist, Assistant Professor of Medicine
Dr Siontis is a Consultant and Board-certified cardiac electrophysiologist in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota, where he is also an Assistant Professor of Medicine. He completed training in Internal Medicine, Cardiology, and Cardiac Electrophysiology at the Mayo Clinic and the University of Michigan. He has clinical and research interests in the… View more
Author(s): Usha Krishnan Added: 3 years ago
Pediatric interventional cardiology was born 40 years ago in 1966, when William Rashkind developed balloon septostomy in neonates with transposition of the great arteries.1 Almost a decade later, Andreas Gruentzig developed coronary angioplasty (between 1972 and 1976), which heralded an explosive era of interventional therapy for adults with heart disease, overshadowing the advances in… View more

Intervention

Heterogeneous Populations